These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25282572)

  • 1. [Tuberculosis prevention].
    Abouda M; Yangui F; Triki M; Kammoun H; Khouani H; Charfi MR
    Rev Pneumol Clin; 2015; 71(2-3):159-67. PubMed ID: 25282572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Childhood tuberculosis].
    Hamzaoui A
    Rev Pneumol Clin; 2015; 71(2-3):168-80. PubMed ID: 24932504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary infection and pulmonary tuberculosis].
    Toujani S; Ben Salah N; Cherif J; Mjid M; Ouahchy Y; Zakhama H; Daghfous J; Beji M; Mehiri-Ben Rhouma N; Louzir B
    Rev Pneumol Clin; 2015; 71(2-3):73-82. PubMed ID: 25749628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
    Starke JR;
    Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Latent tuberculosis infection: diagnosis and treatment].
    Bendayan D; Raz M; Kramer MR
    Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update of the guidelines of the Israeli Association of Rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers].
    Balbir-Gurman A; Lidgi M; Elkayam O
    Harefuah; 2014 Jun; 153(6):359-61, 366. PubMed ID: 25095612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycobacterium tuberculosis infection: signification, role and performance of mesure of cell-mediated immune response].
    Glardon D; Erard V
    Rev Med Suisse; 2014 Apr; 10(425):816-9. PubMed ID: 24791428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review.
    Muñoz L; Santin M
    J Infect; 2013 Apr; 66(4):381-7. PubMed ID: 23298892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive treatment of tuberculin-negative contacts.
    Brickman HF; Beaudry PH
    Can Med Assoc J; 1973 Sep; 109(6):497-8. PubMed ID: 4200523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting it right for children: improving tuberculosis treatment access and new treatment options.
    Brigden G; Furin J; Van Gulik C; Marais B
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):451-61. PubMed ID: 25739933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does an interferon-gamma release assay change practice in possible latent tuberculosis?
    Tiernan JF; Gilhooley S; Jones ME; Chalmers JD; McSparron C; Laurenson IF; Hill AT
    QJM; 2013 Feb; 106(2):139-46. PubMed ID: 23159840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in diagnosis and therapy of childhood tuberculosis.
    Woods CR
    Paediatr Respir Rev; 2006; 7 Suppl 1():S130-1. PubMed ID: 16798538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.